Abstract:OBJECTIVE:To identify the potential mutations in a Chinese pedigree with hypertrophic cardiomyopathy (HCM), and to analyze the genotype-phenotype relationship in this pedigree.METHODS:Clinical history and physical examinations, electrocardiography (ECG), echocardiography (UCG), cardiac magnetic resonance (CMR) data were obtained from 10 members of a three-generation Chinese family with HCM. A total of 96 genes related to hereditary cardiomyopathy were detected by exon and boarding intron analyses in the proband using second-generation sequencing. Mutations identified in the proband were confirmed by bi-directional Sanger sequencing in the rest 9 family members and 300 healthy controls.RESULTS:Three mutations, including MYBPC3-P1208fs, ANK2-H556R and ANK2-P1974H, were identified in this pedigree. MYBPC3-P1208fs gene mutation was detected in 3 family members (proband, his mother and son), while this mutation was not detected in the rest family members. HCM was diagnosed in the proband and his mother by ECG, UCG and CMR. Son of the proband demonstrated early phenotype of HCM: although UCG and CMR were normal, ECG showed sinus bradycardia and paroxysmal supraventricular arrhythmias as well as ST segment changes. The onset age of HCM diagnosis of the proband and his mother was 42 and 50 years old, presented with palpitation and chest pain, and myocardial fibrosis sign in CMR. Furthermore, we found that left ventricular myocardial fibrosis is related to ECG changes (increasing r wave, ST segment change) in the proband and his mother. No HCM phenotype was evidenced in the 7 family members carrying ANK2-H556R and ANK2-P1974H mutations.CONCLUSIONS:Our results show that MYBPC3-P1208fs gene mutation is associated HCM phenotype in this Chinses pedigree. This mutation is associated with myocardial fibrosis and ST changes in HCM phenotype in this pedigree while ANK2-H556R and ANK2-P1974H mutations are not related to HCM phenotype in this family.

A De Novo Mutation of SMYD1 (p.f272l) is Responsible for Hypertrophic Cardiomyopathy in a Chinese Patient.

Inhibition of HSC70 Alleviates Hypertrophic Cardiomyopathy Pathology in Human Induced Pluripotent Stem Cell‐derived Cardiomyocytes with a MYBPC3 Mutation

The Novel Mitochondrial 16S Rrna 2336T>C Mutation is Associated with Hypertrophic Cardiomyopathy

[Advances in the Molecular Pathogenesis of Hypertrophic Cardiomyopathy].

Characteristics of the beta myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy.

Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells.

Abstract 58: Modeling Pathogenesis in Familial Hypertrophic Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells

A novel mutation of the beta myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.

Exome Sequencing Identifies a Novel MYH7 P.g407c Mutation Responsible for Familial Hypertrophic Cardiomyopathy

Mitochondrial Dysfunction Caused by M.2336t > C Mutation with Hypertrophic Cardiomyopathy in Cybrid Cell Lines

A Novel Mutation in the Tropomyosin 1 Gene in a Chinese Patient with Hypertrophic Cardiomyopathy

Two novel mutations of the MYBPC3 gene identified in Chinese families with hypertrophic cardiomyopathy.

MYH7 Gene-Related Mutation P.v878l Identified in a Chinese Family with Hypertrophic Cardiomyopathy.

[A Frame Shift Mutation, Arg346fs Mutation, is Identified in Cardiac Myosin-Binding Protein C Gene in a Chinese Family with Hypertrophic Cardiomyopathy].

[P1208fs Mutation in the Cardiac Myosin Binding Protein C is Associated with Hypertrophic Cardiomyopathy in a Chinese Pedigree].

Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient Ipsc-Derived Cardiomyocytes with MT-RNR2 Mutation.

Identification of a Novel Missense Mutation in the Cardiacβ-myosin Heavy Chain Gene in a Chinese Patient with Sporadic Hypertrophic Cardiomyopathy

Whole-exome Sequencing Reveals MYH7 P.r671c Mutation in Three Different Phenotypes of Familial Hypertrophic Cardiomyopathy.

Mutation of Arg723Gly in Β-Myosin Heavy Chain Gene in Five Chinese Families with Hypertrophic Cardiomyopathy

Next-generation sequencing identifies pathogenic and modifier mutations in a consanguineous Chinese family with hypertrophic cardiomyopathy

Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.